Logo

Armonica Technologies: Victor Esch

Nov 07, 2019

Armonica Technologies, an Albuquerque, New Mexico-based firm developing long-read DNA sequencing technology, has appointed Victor Esch as president and CEO. Esch has more than twenty years of executive and technical experience in the medical device industry, including as CEO of DNA Electronics and CEO of nanoMR, which DNA Electronics acquired in 2015. Esch was a founder of Powervision, which was acquired by Alcon in 2019. He also previously served as chief technology officer for EndoVasix.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.